Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)
Part of paid clinical trials in Kansas City, Missouri.
- Sponsor
- Children's Mercy Hospital Kansas City
- Study ID
- NCT06390371
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 16 Years - 25 Years
- Healthy Volunteers
- Not accepted
Interventions
- Spotlight AQ Survey platform — OTHERA psychosocial assessment pinpointing the needs of patients divided into four domains: Therapy, Psychological, Social, Knowledge which is delivered to health care providers to guide their in clinic visits
Study Details
The goal of this clinical trial is to compare the Spotlight AQ survey platform to the standard of care (SOC) pre-clinic assessment in adolescents \& young adults (16-25 years old) with Type 1 Diabetes (T1D). The main questions it aims to answer are: * Does using the Spotlight AQ survey in clinic decrease the A1c in the people who use it? * Do patients and healthcare providers like using the spotlight AQ survey? Participants will use the Spotlight AQ survey before coming in to two standard of care T1D clinic visits Participants will fill out surveys describing how they feel about using the Spotlight AQ survey. Some participants may be asked to do an interview to talk about how they feel about the Spotlight AQ survey.
Key Dates
- Start date
- May 27, 2024
- Status verified
- Jan 2026
- Primary completion
- Jun 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Intervention (Spotlight AQ)Spotlight AQ is an Artificial Intelligence (AI) powered adaptive survey which identifies the main concerns and gaps in patients tailored to their specific needs in preparation for clinic visits
- No Intervention: Standard of CareThe pre-clinic survey typically given to patients before clinic visits at each institution
Primary Outcome Measure
HbA1c [ Time Frame: 3 months (approximately) ]
Central Contacts
- Priscilla Connell, MPH816-601-4543
- Cintya Schweisberger, DO
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Mercy | Kansas City | Missouri | 64111 | Cintya Schweisberger, DO |
Find similar trials in Kansas City, MO
Related Studies
- Type 1 Diabetes Extension StudyRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · San Francisco, California
- CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)PHASE1/PHASE2 · Recruiting · COUR Pharmaceutical Development Company, Inc. · Tucson, Arizona
- A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 DiabetesPHASE3 · Recruiting · Sanofi · Scottsdale, Arizona
- Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft LossRecruiting · Rodolfo Alejandro · Miami, Florida